Metabolomics analysis of gut barrier dysfunction in a trauma-hemorrhagic shock rat model. 2019

Zhongqi Li, and Jian Li, and Shouwei Zhang, and Gang Chen, and Shaohua Chi, and Xugang Li, and Fei Guo, and Jianbo Zhu, and Baoxi Sun
Department of Critical Care Medicine, Rizhao People's Hospital, Rizhao, Shandong, 276800, China.

Intestinal barrier dysfunction has been implicated in the development of multiorgan dysfunction syndrome caused by the trauma-hemorrhagic shock (THS). However, the mechanisms underlying THS-induced gut barrier injury are still poorly understood. In the present study, we used the metabolomics analysis to test the hypothesis that altered metabolites might be related to the development of THS-induced barrier dysfunction in the large intestine. Under the induction of THS, gut barrier failure was characterized by injury of permeability and mucus layer, which were companied by the decreased expression of zonula occludens-1 in the colon and increased levels of inflammatory factors including tumor necrosis factor-α, interferon-γ, interleukin (IL)-6, and IL-1β in the serum. A total of 16 differential metabolites were identified in colonic tissues from THS-treated rats compared with control rats. These altered metabolites included dihydroxy acetone phosphate, ribose-5-phosphate, fructose, glyceric acid, succinic acid, and adenosine, which are critical intermediates or end products that are involved in pentose phosphate pathway, glycolysis, and tricarboxylic acid cycle as well as mitochondrial adenosine triphosphate biosynthesis. These findings may offer important insight into the metabolic alterations in THS-treated gut injury, which will be helpful for developing effective metabolites-based strategies to prevent THS-induced gut barrier dysfunction.

UI MeSH Term Description Entries
D007413 Intestinal Mucosa Lining of the INTESTINES, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. In the SMALL INTESTINE, the mucosa is characterized by a series of folds and abundance of absorptive cells (ENTEROCYTES) with MICROVILLI. Intestinal Epithelium,Intestinal Glands,Epithelium, Intestinal,Gland, Intestinal,Glands, Intestinal,Intestinal Gland,Mucosa, Intestinal
D008928 Mitochondria Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon genes within the nucleus of the cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed) Mitochondrial Contraction,Mitochondrion,Contraction, Mitochondrial,Contractions, Mitochondrial,Mitochondrial Contractions
D009102 Multiple Organ Failure A progressive condition usually characterized by combined failure of several organs such as the lungs, liver, kidney, along with some clotting mechanisms, usually postinjury or postoperative. MODS,Multiple Organ Dysfunction Syndrome,Organ Dysfunction Syndrome, Multiple,Organ Failure, Multiple,Failure, Multiple Organ,Multiple Organ Failures
D010539 Permeability Property of membranes and other structures to permit passage of light, heat, gases, liquids, metabolites, and mineral ions. Permeabilities
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012771 Shock, Hemorrhagic Acute hemorrhage or excessive fluid loss resulting in HYPOVOLEMIA. Hemorrhagic Shock
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D015850 Interleukin-6 A cytokine that stimulates the growth and differentiation of B-LYMPHOCYTES and is also a growth factor for HYBRIDOMAS and plasmacytomas. It is produced by many different cells including T-LYMPHOCYTES; MONOCYTES; and FIBROBLASTS. Hepatocyte-Stimulating Factor,Hybridoma Growth Factor,IL-6,MGI-2,Myeloid Differentiation-Inducing Protein,Plasmacytoma Growth Factor,B Cell Stimulatory Factor-2,B-Cell Differentiation Factor,B-Cell Differentiation Factor-2,B-Cell Stimulatory Factor 2,B-Cell Stimulatory Factor-2,BSF-2,Differentiation Factor, B-Cell,Differentiation Factor-2, B-Cell,IFN-beta 2,IL6,Interferon beta-2,B Cell Differentiation Factor,B Cell Differentiation Factor 2,B Cell Stimulatory Factor 2,Differentiation Factor 2, B Cell,Differentiation Factor, B Cell,Differentiation-Inducing Protein, Myeloid,Growth Factor, Hybridoma,Growth Factor, Plasmacytoma,Hepatocyte Stimulating Factor,Interferon beta 2,Interleukin 6,Myeloid Differentiation Inducing Protein,beta-2, Interferon
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats

Related Publications

Zhongqi Li, and Jian Li, and Shouwei Zhang, and Gang Chen, and Shaohua Chi, and Xugang Li, and Fei Guo, and Jianbo Zhu, and Baoxi Sun
November 2017, The journal of trauma and acute care surgery,
Zhongqi Li, and Jian Li, and Shouwei Zhang, and Gang Chen, and Shaohua Chi, and Xugang Li, and Fei Guo, and Jianbo Zhu, and Baoxi Sun
November 2011, The Journal of trauma,
Zhongqi Li, and Jian Li, and Shouwei Zhang, and Gang Chen, and Shaohua Chi, and Xugang Li, and Fei Guo, and Jianbo Zhu, and Baoxi Sun
February 1998, The Journal of surgical research,
Zhongqi Li, and Jian Li, and Shouwei Zhang, and Gang Chen, and Shaohua Chi, and Xugang Li, and Fei Guo, and Jianbo Zhu, and Baoxi Sun
November 2011, Neurogastroenterology and motility,
Zhongqi Li, and Jian Li, and Shouwei Zhang, and Gang Chen, and Shaohua Chi, and Xugang Li, and Fei Guo, and Jianbo Zhu, and Baoxi Sun
January 2006, Molecular medicine (Cambridge, Mass.),
Zhongqi Li, and Jian Li, and Shouwei Zhang, and Gang Chen, and Shaohua Chi, and Xugang Li, and Fei Guo, and Jianbo Zhu, and Baoxi Sun
September 2013, World journal of gastroenterology,
Zhongqi Li, and Jian Li, and Shouwei Zhang, and Gang Chen, and Shaohua Chi, and Xugang Li, and Fei Guo, and Jianbo Zhu, and Baoxi Sun
November 2018, Pathology, research and practice,
Zhongqi Li, and Jian Li, and Shouwei Zhang, and Gang Chen, and Shaohua Chi, and Xugang Li, and Fei Guo, and Jianbo Zhu, and Baoxi Sun
September 2003, American journal of physiology. Gastrointestinal and liver physiology,
Zhongqi Li, and Jian Li, and Shouwei Zhang, and Gang Chen, and Shaohua Chi, and Xugang Li, and Fei Guo, and Jianbo Zhu, and Baoxi Sun
January 1992, JPEN. Journal of parenteral and enteral nutrition,
Zhongqi Li, and Jian Li, and Shouwei Zhang, and Gang Chen, and Shaohua Chi, and Xugang Li, and Fei Guo, and Jianbo Zhu, and Baoxi Sun
January 1998, Critical care medicine,
Copied contents to your clipboard!